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Inhibition of Mast Cell Degranulation by a Chimeric Toxin Containing a Novel
Phosphatidylinositol-3,4,5-Triphosphate Phosphatase
Abstract
It is well established that many cell functions are controlled by the PI-3K signaling pathway and the
signaling lipid, phosphatidylinositol-3,4,5-triphosphate (PIP3). This is particularly true for mast cells which
play a key regulatory role in allergy and inflammation through activation via high-affinity IgE receptors
(FcɛRI) leading to activation of signaling cascades and subsequent release of histamine and other proinflammatory mediators. A pivotal component of this cascade is the activation of PI-3K and a rise in
intracellular levels of PIP3. In this study, we developed a novel chimeric toxin that selectively binds to
mast cells and which functions as a PIP3 phosphatase. Specifically, the chimeric toxin was composed of
the FcɛRI binding region of IgE and the active subunit of the cytolethal distending toxin, CdtB, which we
have recently demonstrated to function as a PIP3 phosphatase. We demonstrate that the chimeric toxin
retains PIP3 phosphatase activity and selectively binds to mast cells. Moreover, the toxin is capable of
altering intracellular levels of PIP3, block antigen-induced Akt phosphorylation and degranulation. These
studies provide further evidence for the pivotal role of PIP3 in regulating mast cell activation and for this
signaling lipid serving as a novel target for therapeutic intervention of mast cell-mediated disease.
Moreover, these studies provide evidence for the utilization of CdtB as a novel therapeutic agent for
targeting the PI-3K signaling pathway.
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